The Role of RNA Interference in West Nile Virus Diversification

RNA 干扰在西尼罗河病毒多样化中的作用

基本信息

  • 批准号:
    7928206
  • 负责人:
  • 金额:
    $ 5.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-01 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our long-term objectives are to understand the evolution of arboviruses in the context of their transmission cycles and how this impacts viral emergence, adaptation and persistence. WNV genetic diversity is greater in mosquitoes than birds in both nature and the laboratory. The exact reasons for this difference are unknown, but may be the result of divergent host antiviral immune responses. Vertebrates respond to viral infections mainly via type-1 interferon and natural killer cells, whereas mosquitoes rely on RNA interference (RNAi) as an intracellular defense mechanism to control viral infections. The sequence-specificity of RNAi may drive increases in genetic diversity through negative frequency-dependent selection within host cells, and consequently within hosts. Therefore, we propose a series of in vitro and in vivo experiments to elucidate the contribution of the RNAi-based antiviral response on WNV genetic diversification. In Aim 1 we will determine if induction and/or suppression of the RNAi pathway in mosquito and chicken cells results in gains and reductions in WNV genetic diversity, respectively. Likewise, Aim 2 will determine if induction and/or suppression of the RNAi pathway in Cx. pipiens results in gains or reductions in WNV genetic diversity, respectively. Using short-hairpin RNAs in Aim 1 we will either induce (WNV-specific ShRNAs) or suppress (dcr-2 and ago-2-specific shRNAs) the RNAi response in mosquito and chicken cell culture and assess the impacts on WNV genetic diversity. Similarly, long, double-stranded RNA molecules either targeting the WNV genome or dcr-2 and ago-2 will be used to test for similar outcomes in adult female Cx. pipiens. For both Aims suppression will be monitored by Q-RT-PCR and viral population diversity analyzed by high-throughput sequencing. The overall hypothesis is that induction of the RNAi pathway with either WNV-specific shRNAs or dsRNAs will result in genetic gains in mosquito and chicken cells and adult mosquitoes. Alternatively, suppression of the RNAi response with dcr-2 and ago-2-specific shRNAs or dsRNAs will result in decreases in genetic diversity in adult mosquitoes and mosquito cell culture, but not in chicken cell culture. PUBLIC HEALTH RELEVANCE: The introduction and adaptation of arboviruses to new ecological niches pose an ongoing threat to human health. The recent epidemics of West Nile virus in North America and chikungunya virus (CHIKV) in the Eastern hemisphere highlight the potential for other arbovirus such as dengue virus (DENV) and Rift Valley fever virus (RVFV) to emerge in non-endemic regions. Understanding the adaptive mechanisms of arboviruses is paramount to developing and implementing effective control measures.
描述(由申请人提供):我们的长期目标是了解虫媒病毒在其传播周期中的进化,以及这如何影响病毒的出现、适应和持续性。在自然界和实验室中,蚊子中的西尼罗河病毒遗传多样性大于鸟类。这种差异的确切原因尚不清楚,但可能是不同的宿主抗病毒免疫反应的结果。脊椎动物主要通过1型干扰素和自然杀伤细胞对病毒感染做出反应,而蚊子则依赖RNA干扰(RNAi)作为细胞内防御机制来控制病毒感染。RNAi的序列特异性可以通过宿主细胞内的负频率依赖性选择,从而在宿主内驱动遗传多样性的增加。因此,我们提出了一系列的体外和体内实验,以阐明基于RNAi的抗病毒反应对西尼罗河病毒遗传多样性的贡献。在目标1中,我们将确定蚊子和鸡细胞中RNAi途径的诱导和/或抑制是否分别导致WNV遗传多样性的增加和减少。同样,目标2将确定Cx中RNAi途径的诱导和/或抑制。pipiens分别导致西尼罗河病毒遗传多样性的增加或减少。在目标1中使用短发夹RNA,我们将在蚊子和鸡细胞培养物中诱导(WNV特异性shRNA)或抑制(dcr-2和ago-2特异性shRNA)RNAi反应,并评估对WNV遗传多样性的影响。类似地,靶向WNV基因组或dcr-2和ago-2的长双链RNA分子将用于测试成年女性Cx的类似结果。pipiens。对于这两个目的,将通过Q-RT-PCR监测抑制,并通过高通量测序分析病毒群体多样性。总体假设是,用WNV特异性shRNA或dsRNA诱导RNAi途径将导致蚊子和鸡细胞以及成年蚊子的遗传增益。或者,用dcr-2和ago-2特异性shRNA或dsRNA抑制RNAi应答将导致成年蚊子和蚊子细胞培养物中的遗传多样性降低,但在鸡细胞培养物中不降低。公共卫生相关性: 虫媒病毒的引入和适应新的生态位对人类健康构成持续的威胁。最近西尼罗河病毒在北美和基孔肯雅病毒(CHIKV)在东半球的流行突出了其他虫媒病毒,如登革热病毒(DENV)和裂谷热病毒(RVFV)在非流行地区出现的可能性。了解虫媒病毒的适应机制对于制定和实施有效的控制措施至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Douglas E. Brackney其他文献

Douglas E. Brackney的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Douglas E. Brackney', 18)}}的其他基金

The role of autophagy in Aedes aegypti vector competence for dengue virus type 2
自噬在埃及伊蚊载体抵抗登革热病毒 2 型能力中的作用
  • 批准号:
    8510060
  • 财政年份:
    2015
  • 资助金额:
    $ 5.05万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 5.05万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 5.05万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 5.05万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 5.05万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 5.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了